Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

247 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
KRAS Mutations Predict Response and Outcome in Advanced Lung Adenocarcinoma Patients Receiving First-Line Bevacizumab and Platinum-Based Chemotherapy.
Ghimessy AK, Gellert A, Schlegl E, Hegedus B, Raso E, Barbai T, Timar J, Ostoros G, Megyesfalvi Z, Gieszer B, Moldvay J, Renyi-Vamos F, Lohinai Z, Hoda MA, Klikovits T, Klepetko W, Laszlo V, Dome B. Ghimessy AK, et al. Cancers (Basel). 2019 Oct 9;11(10):1514. doi: 10.3390/cancers11101514. Cancers (Basel). 2019. PMID: 31600989 Free PMC article.
Current therapy of KRAS-mutant lung cancer.
Ghimessy A, Radeczky P, Laszlo V, Hegedus B, Renyi-Vamos F, Fillinger J, Klepetko W, Lang C, Dome B, Megyesfalvi Z. Ghimessy A, et al. Cancer Metastasis Rev. 2020 Dec;39(4):1159-1177. doi: 10.1007/s10555-020-09903-9. Cancer Metastasis Rev. 2020. PMID: 32548736 Free PMC article. Review.
[Therapeutic possibilities in KRAS-mutant lung adenocarcinoma].
Radeczky P, Ghimessy Á, Berta J, László V, Hegedűs B, Rényi-Vámos F, Fillinger J, Megyesfalvi Z, Döme B. Radeczky P, et al. Magy Onkol. 2020 Sep 23;64(3):231-244. Epub 2020 Aug 6. Magy Onkol. 2020. PMID: 33196710 Free article. Review. Hungarian.
The landscape of small cell lung cancer metastases: Organ specificity and timing.
Megyesfalvi Z, Tallosy B, Pipek O, Fillinger J, Lang C, Klikovits T, Schwendenwein A, Hoda MA, Renyi-Vamos F, Laszlo V, Rezeli M, Moldvay J, Dome B. Megyesfalvi Z, et al. Thorac Cancer. 2021 Mar;12(6):914-923. doi: 10.1111/1759-7714.13854. Epub 2021 Feb 3. Thorac Cancer. 2021. PMID: 33533174 Free PMC article.
EGFR variant allele frequency predicts EGFR-TKI efficacy in lung adenocarcinoma: a multicenter study.
Gieszer B, Megyesfalvi Z, Dulai V, Papay J, Kovalszky I, Timar J, Fillinger J, Harko T, Pipek O, Teglasi V, Regos E, Papp G, Szallasi Z, Laszlo V, Renyi-Vamos F, Galffy G, Bodor C, Dome B, Moldvay J. Gieszer B, et al. Transl Lung Cancer Res. 2021 Feb;10(2):662-674. doi: 10.21037/tlcr-20-814. Transl Lung Cancer Res. 2021. PMID: 33718012 Free PMC article.
Clinical relevance of circulating activin A and follistatin in small cell lung cancer.
Barany N, Rozsas A, Megyesfalvi Z, Grusch M, Hegedus B, Lang C, Boettiger K, Schwendenwein A, Tisza A, Renyi-Vamos F, Schelch K, Hoetzenecker K, Hoda MA, Paku S, Laszlo V, Dome B. Barany N, et al. Lung Cancer. 2021 Nov;161:128-135. doi: 10.1016/j.lungcan.2021.09.008. Epub 2021 Sep 20. Lung Cancer. 2021. PMID: 34583221 Free article.
247 results